Dextera Surgical announces preliminary Q3 results
Apr. 24, 2017
Dextera Surgical (NASDAQ:DXTR) announces preliminary Q3 results.
- Total revenue of ~$1.1M, including MicroCutter product sales of ~$0.5M.
- Operating costs & expenses and net loss of ~$5.3M and ~$4.4M respectively.
- Cash balance of ~$2.5M and total stockholders’ deficit of ~$3.7M.
Q3 financial results will be reported on May 4, 2017, after the markets close.
invest at your own risk, based on your own due diligence, at your own risk tolerance